With an abundance of medical device products vying for attention and approval in the marketplace, the issue of product quality has become a chief concern for the medical community.
British scientists have discovered a next-generation wearable brain scanner that can be worn like a helmet and allows patients to move freely while being scanned. This is said to be a development that could have great impact on neural care for children and the elderly.
The Guardian Connect monitoring system, a small wireless device for people with diabetes, has been approved by the Food & Drug Administration. According to its manufacturer, Medtronics, the GCM system is the first smart standalone system to help people with diabetes stay ahead of high and low glucose events.
New medical devices are on the verge of transforming healthcare as we know it. But as hackers disrupt healthcare facilities, security and IT experts have identified these devices to be a source of cyber infections.
A research team at the National University of Singapore has developed a soft, flexible microfiber sensor that can be used for healthcare monitoring and diagnosis. The sensor is ultrathin, like a strand of human hair.
Developed by Dynamic Brain Labs, LLC in Tokyo, this cutting edge device is a noninvasive sensor for blood glucose levels. It uses optical technology and signal processing. It does not require finger pricking.
Is the Food and Drug Administration planning a more constructive role in the creation, development and regulation of medical devices?
It would appear so.
Because workout intensity is critically important to endurance athletes, many of them will likely welcome a new wearable device called the “Hex” from Humon, which measures muscle oxygen levels in real time. The device’s capabilities allow athletes to adjust exertion levels while they are in the midst of training.
The primary issue that consumes the majority of the burden of healthcare costs in the United States is preventable chronic disease: while the most prevalent health conditions are simultaneously the most avoidable, they continue to cost the country’s budget billions of dollars. While overall numbers have decreased since 2010, when chronic disease cost the U.S. a total of $315 billion, morbid obesity rates have continued to rapidly spike—a condition that leads to a range of critical health issues including heart disease, diabetes, and stroke.
Primary care providers have long faced the struggle of determining how to implement best practice care for patients diagnosed with chronic diseases. Recent studies indicate that almost half of the entire U.S. population has at least one chronic health condition—including heart disease, cancer, diabetes, obesity, or arthritis. Statistics designate these health care treatments costs to account for 86% of cumulative national healthcare spending, and the CDC reports that chronic conditions are the leading causes of death and disability in the country.
Recent data and statistics demonstrate that overall American life expectancy has dropped for the first time in a decade, spurring an urgent and pressing need for the advent and proliferation of medical technology—coupled with scientific progress and laws to encourage innovation.
While the research points to specific factors that have lowered rates of mortality, including increased obesity, long-term unemployment, and a resurgence of chronic diseases, the studies incontrovertibly suggest the critical need to provide enhanced ‘life-saving and life-prolonging’ therapies and treatments.
There is no specific way to address the divergence of issues regarding lowered life expectancy, but there are particular measures that must be undertaken. These include enacting evidence-based policies that spur innovation, and further eliminating any roadblocks to America’s inventors.